I found the session informative and riveting. It ranked among the best training sessions I’ve attended in the past
10 years. When I don’t need afternoon coffee to keep me awake, I know I’ve stumbled into something good.
— Len Resto, CPCU Vice President, Senior Client Executive USI Insurance Services

"How Concerned are You About CyberSecurity in Your Work?"
We asked this question at several conferences this spring. Clearly, today's pharmaceutical and biotech researchers realize that they play a key role in building precious databases.

Collaborations that include information technology partners continue to grow into a critical backbone within the Pharma and Biotech world.  Phrases such as “The Cloud”, “Big Data”, “Wireless” and “Collaboration” dominate the board rooms, resulting in IT groups taking on greater responsibility in managing and securing data in this complex environment.  

Join experts from across biomedical research to help integrate the concerns of scientists, enterprise information technologists and patients.


Miranda Alfonso-Williams
Principal Consultant
WAM Consulting Group

Colin Morgan, CISSP, GPEN
Sr. Information Security Manager /
Information Security Officer 
Johnson & Johnson

Suzanne Schwartz, MD MBA
Director, Emergency Preparedness/Operations and Medical Countermeasures Center for Devices and Radiological Health (CDRH), FDA

Hardik Shah
Dark Matter
LifeMap Solutions
Mount Sinai School of Medicine

John Wilbanks
Chief Commons Officer
Sage Bionetworks

Click to Download the Agenda 

Symposium, 8:30-2:30

The morning program will address the breadth of issues that concern all who generate, analyze, and share precious research data throughout the process. For both IT professionals and managers, this unique focus upon strategies relevant specifically to the pharma/biotech and device industries will help all responsible parties to deepen their understanding and perspectives.

Workshop, 2:30-5:00 pm
Includes Documentation and a Workbook to help you conduct your own risk analysis: You will work with experts in cybersecurity risk assessment and policy planning to go through the nuts and bolts of developing a resilient and comprehensive strategy. This will be most interesting for IT professionals, though Discovery, Development, and Device managers will benefit from an understanding of the issues facing their teams.


Pharma and Biotech companies are pushing the envelope with where they store data, how they collaborate with institutions for clinical trials and how they build technology in medical devices.

The swiftly changing landscape impacts organizational risk level, making it critical to ensure conversations regarding information security are occurring, and that those conversations are driving risk decisions.  

To discuss these topics further, The BioPharma Research Council (BRC) is convening Internet of Medical Things: CyberSecurity in Discovery, Development, & Devices, a symposium covering both common industry risks and IT security topics of special interest to the pharmaceutical and biotechnology community.  

Topic areas include:

  • Cybersecurity of Medical Devices 
  • Protecting Patient Data and Safety of the Product
  • Cloud Computing’s Impact on Pharma-Biotech
  • Strategies to balance security, safety, privacy, internal controls, and liability
  • Addressing security challenges in a regulated environment
  • Clinical trials data protection



Screen Shot 2015-07-28 at 3.23.24 PM.png


Committee Members:

Colin Morgan, Chair
Sr. Manager, IT Risk Assurance
Janssen Pharmaceutical Companies
of Johnson & Johnson

Nicholas Bergman
Senior Principal Investigator, Genomics
National Biodefense Analysis
and Countermeasures Center

Rebecca Herold
CEO, The Privacy Professor
Chief Visionary Officer / Co-Owner,
HIPAA Compliance Tools

Miranda Alfonso-Williams, HCISSP, 

Principal Consultant
WAM Consulting Group

Jordan McGrew
Cybersecurity Consultant

Hardik Shah
Dark Matter
LifeMap Solutions
Mount Sinai School of Medicine

Judith Sheft
Associate Vice President,
Technology Development
New Jersey Institute of Technology

For the BRC:

Rich Brandwein

Ronnye Schreiber

Joanne Gere
Executive Director
BioPharma Research Council

Tom Fare, Ph.D.
Director, Strategic Alliances
BioPharma Research Council

Who Will Attend?

  • Medical Device Ecosystem
  • Providers 
  • Payers
  • Pharmaceutical/OTC manufacturers
  • Research organizations, universities, institutes
  • Device manufacturers
  • Component manufacturers
  • Information technology providers
  • Information security professionals
  • Public sector
  • Clinical/Contract Research Organizations (CROs)
  • Associations & Advocacy Groups